Radiation dose affected by mammographic composition and breast size: first application of a radiation dose management system for full-field digital mammography in Korean women

Radiation dose and cancer induction risk from diagnostic mammography in Dubai tertiary hospital

This study aimed to estimate radiation dose and to assess the probability of cancer induction risk among patients who underwent mammography procedure in tertiary hospital in Dubai. After obtained approval from the research ethic committee,155 female patients with an average age of 55.5 ± 12.7 years-old were selected as subjects. Acquisition parameter, tube potential, tube current, compression force, and entrance dose were recorded and analyzed. The Mean Glandular Dose (MGD) were determined by applying the Dance formula, considering the entrance surface air kerma (ESAK) and other conversion coefficients. Patient age-data was used to assess the cancer induction risk from the acquisition, based on Biological Effects of Ionizing Radiation VII (BEIR VII) report, and standardizing the breast thickness. The MGD ranged between 0.7 and 3.5 mGy for medio-lateral oblique (MLO) and for cranio-caudal (CC) projections, respectively. The median MGD for CC lies between 1.4 mGy and 2.1 mGy, with an average of 1.7 mGy. Additionally, the MGD for the 3rd quartile spans a two-fold range. In a population of 100,000 exposed to MLO projection, the cancer incidence risk for a 37-year-old female was 6 times higher than that of a 60-year-old female, at 3.2 out of 100,000 and 0.5 out of 100,000, respectively. The LAR for the 35-45 years age group is 1.91 ± 0.66, decreasing to 0.27 ± 0.07 for those over 65 years. The CC view also shows a decrease from 1.73 ± 0.57 to 0.23 ± 0.04. The mammographic screening radiation dose and the risks that have been found in Dubai all fall within the recommended range, thereby calling for more works of research to determine the progress made in radiation protection. The study has provided additional evidence that the radiation dose used in current practice can be improved.

Establishing Diagnostic Reference Levels for Mammography Digital Breast Tomosynthesis, Contrast Enhance, Implants, Spot Compression, Magnification and Stereotactic Biopsy in Dubai Health Sector

The aim of this patient dose review is to establish a thorough diagnostic reference level (DRL) system. This entails calculating a DRL value for each possible image technique/view considered to perform a diagnostic mammogram in our practice. Diagnostic mammographies from a total of 1191 patients who underwent a diagnostic mammogram study in our designated diagnostic mammography center were collected and retrospectively analyzed. The DRL representing our health sector was set as the median of the mean glandular dose (MGD) for each possible image technique/view, including the 2D standard bilateral craniocaudal (LCC/RCC) and mediolateral oblique (LMLO/RMLO), the 2D bilateral spot compression CC and MLO (RSCC/LSCC and RSMLO/LSMLO), the 2D bilateral spot compression with magnification (RMSCC/LMSCC and RMSMLO/LMSMLO), the 3D digital breast tomosynthesis CC and MLO (RCC/LCC and RMLO/LMLO), the 2D bilateral implant CC and MLO (RIMCC/LIMCC and RIMMLO/LIMMLO), the 2D bilateral contrast enhanced CC and MLO (RCECC/LCECC and RCEMLO/LCEMLO) and the 2D bilateral stereotactic biopsy guided CC (SBRCC/SBLCC). This patient dose review revealed that the highest MGD was associated with the 2D bilateral spot compression with magnification (MSCC/MSMLO) image view. For the compressed breast thickness (CBT) group 60-69 mm, the median and 75th percentile of the MGD values obtained were MSCC: 3.35 and 3.96, MSMLO: 4.14 and 5.25 mGy respectively. Obvious MGD variations were witnessed across the different possible views even for the same CBT group. Our results are in line with the published DRLs when using same statistical quantity and CBT group.

Evaluating Factors Affecting Mean Glandular Dose in Mammography: Insights from a Retrospective Study in Dubai

BACKGROUND/OBJECTIVE

This study evaluates the mean glandular dose (MGD) in mammography screening for women aged 40-69 in Dubai, based on a retrospective analysis of a dose survey involving 2599 participants.

METHODS

MGD was calculated using the Dance formula.

RESULTS

The average MGD was 0.96 ± 0.39 mGy for mediolateral oblique (MLO) views and 0.81 ± 0.33 mGy for craniocaudal (CC) views. Weak inverse correlations were found between age and organ dose (OD) for both views, while a direct relationship was observed between breast thickness and entrance skin dose (ESD). In adjusted models, ESD was strongly associated with MGD (β = 1.04, 95% CI: 0.97, 1.09), while OD showed a moderate association (β = 0.44, 95% CI: 0.40, 0.49). Significant variations in ESD, OD, and MGD were noted across age groups and breast thicknesses.

CONCLUSIONS

Lower MGD indicates reduced radiation exposure risk, while higher MGD in MLO views suggests improved imaging quality. Monitoring and optimizing MGD are essential for enhancing patient safety and screening efficacy.

Screening Mammography Diagnostic Reference Level System According to Compressed Breast Thickness: Dubai Health

Screening mammography is considered to be the most effective means for the early detection of breast cancer. However, epidemiological studies suggest that longitudinal exposure to screening mammography may raise breast cancer radiation-induced risk, which begs the need for optimization and internal auditing. The present work aims to establish a comprehensive well-structured Diagnostic Reference Level (DRL) system that can be confidently used to highlight healthcare centers in need of urgent action, as well as cases exceeding the dose notification level. Screening mammographies from a total of 2048 women who underwent screening mammography at seven different healthcare centers were collected and retrospectively analyzed. The typical DRL for each healthcare center was established and defined as per (A) bilateral image view (left craniocaudal (LCC), right craniocaudal (RCC), left mediolateral oblique (LMLO), and right mediolateral oblique (RMLO)) and (B) structured compressed breast thickness (CBT) criteria. Following this, the local DRL value was established per the bilateral image views for each CBT group. Screening mammography data from a total of 8877 images were used to build this comprehensive DRL system (LCC: 2163, RCC: 2206, LMLO: 2288, and RMLO: 2220). CBTs were classified into eight groups of <20 mm, 20-29 mm, 30-39 mm, 40-49 mm, 50-59 mm, 60-69 mm, 70-79 mm, 80-89 mm, and 90-110 mm. Using the Kruskal-Wallis test, significant dose differences were observed between all seven healthcare centers offering screening mammography. The local DRL values defined per bilateral image views for the CBT group 60-69 mm were (1.24 LCC, 1.23 RCC, 1.34 LMLO, and 1.32 RMLO) mGy. The local DRL defined per bilateral image view for a specific CBT highlighted at least one healthcare center in need of optimization. Such comprehensive DRL system is efficient, easy to use, and very clinically effective.

Estimating Local Diagnostic Reference Levels for Mammography in Dubai

As the total volume of mammograms in Dubai is increasing consistently, it is crucial to focus on the process of dose optimization by determining dose reference levels for such sensitive radiographic examinations as mammography. This work aimed to determine local diagnostic reference levels (DRLs) for mammography procedures in Dubai at different ranges of breast thickness. A total of 2599 anonymized mammograms were randomly retrieved from a central dose survey database. Mammographic cases for screening women aged from 40 to 69 years were included, while cases of breast implants and breast thickness outside the range of 20-100 mm were excluded. Mean, median, and 75 percentiles were obtained for the mean glandular dose (MGD) distribution of each mammography projection for all compressed breast thickness (CBT) ranges. The local DRLs for mammography in Dubai were found to be between 0.80 mGy and 0.82 mGy for the craniocaudal (CC) projection and between 0.89 mGy and 0.971.8 mGy for the mediolateral oblique (MLO) projection. Local DRLs were proposed according to different breast thicknesses, starting from 20 to 100 mm. All groups of CBT showed a slight difference in MGD values, with higher values in MLO views rather than CC views. The local DRLs in this study were lower than some other Middle Eastern countries and lower than the standard reference levels reported by the International Atomic Energy Agency (IAEA) at 3 mGy/view.

Evaluation of patient dose during a digital breast tomosynthesis

INTRODUCTION

When the patient dose in mammography is assessed, it is important to evaluate both average glandular dose (AGD) and entrance surface dose (ESD). A dose survey on both AGD and ESD in mammography has never been studied in Sri Lanka. Therefore, the present study aimed to evaluate the patient dose received during a full-field digital breast tomosynthesis (DBT) examination by determining both AGD and ESD.

METHODS

The study was performed on 140 patients who underwent DBT examination. The AGD, ESD, compression breast thickness (CBT), half-value layer (HVL), target/filter combination, kVp, and mAs values were obtained from the machine, and AGD for each projection was calculated using the equation proposed by the Dance 2011.

RESULTS

The measured mean AGDs and ESDs of both the breasts were statistically significantly lower than the reference values given by European protocol (p < 0.05). There were no statistically significant differences in both AGDs and ESDs between the right and left breast, between right craniocauidal (RCC) and left craniocaudal (LCC), and between right mediolateral oblique (RMLO) and left mediolateral oblique (LMLO) examinations (p > 0.05). The measured median AGDs and ESDs received for MLO projections of both breasts were statistically significantly higher than that of CC projections (p < 0.05).

CONCLUSION

The patients receive a low radiation dose during their DBT examination with both lowered AGD and ESD than the recommended values.

IMPLICATIONS FOR PRACTICE

The results can be used as a baseline to optimize the radiation dose in mammography in Sri Lanka.

Assessment of male patients' average glandular dose during mammography procedure

Breast cancer is a common malignancy for females (25% of female cancers) and also has low incidence in males. It was estimated that 1% of all breast malignancies occur in males with mortality rate about 20%, with annual increase in incidence. Risk factors include age, family history, exposure to ionizing radiation and high estrogen and low of androgens hormones level. Diagnosis and screening are challenging due to limiting effectiveness of breast cancer screening. Therefore, patients may expose to ionizing radiation that may contribute in breast cancer incidence in males. In literature, limited studies were published regarding radiation exposure for males during mammography. The objective of this research is to quantify patient doses during male mammogram and to estimate the projected radiogenic risk during the procedure. In total, 42 male patients were undergone mammogram for breast cancer diagnosis during two consecutive years. The mean and range of patient age (years) is 45 (23-80). The mean and standard deviation (SD) of the peak tube potential and tube current time product are 28.64 ± 2. and 149 ± 35.1, respectively. The mean, and range of patients' entrance surface air kerma (ESAK, mGy) per single breast procedure was 5.3 (0.47-27.5). Male patient's received comparable radiation dose per mammogram compared to female procedures. With increasing incidence of male breast cancer, proper guidelines are necessary for the mammographic procedure are necessary to reduce unnecessary radiation doses and radiogenic risk.

The Impact of Data Management on the Achievable Dose and Efficiency of Mammography and Radiography During the COVID-19 Era: A Facility-Based Cohort Study

Purpose

To evaluate the impact of using computational data management resources and analytical software on radiation doses in mammography and radiography during the COVID-19 pandemic, develop departmental diagnostic reference levels (DRLs), and describe achievable doses (ADs) for mammography and radiography based on measured dose parameters.

Patients and Methods

This ambispective cohort study enrolled 795 and 12,115 patients who underwent mammography and radiography, respectively, at the King Fahd Hospital of the University, Al-Khobar City, Saudi Arabia between May 25 and November 4, 2021. Demographic data were acquired from patients' electronic medical charts. Data on mammographic and radiographic dose determinants were acquired from the data management software. Based on the time when the data management software was operational in the institute, the study was divided into the pre-implementation and post-implementation phases. Continuous and categorical variables were compared between the two phases using an unpaired t-test and the chi-square test.

Results

The median accumulated average glandular dose (AGD; a mammographic dose determinant) in the post-implementation phase was three-fold higher than that in the pre-implementation phase. The average mammographic exposure time in the post-implementation phase was 16.3 ms shorter than that in the pre-implementation phase. Furthermore, the median values of the dose area product ([DAP], a radiographic dose determinant) were 9.72 and 19.4 cGycm² in the pre-implementation and post-implementation phases, respectively.

Conclusion

Although the data management software used in this study helped reduce the radiation exposure time by 16.3 ms in mammography, its impact on the mean accumulated AGD was unfavorable. Similarly, radiographic exposure indices, including DAP, tube voltage, tube current, and exposure time, were not significantly different after the data management software was implemented. Close monitoring of patient radiation doses in mammography and radiography, and dose reduction will become possible if imaging facilities use DRLs and ADs via automated systems.

Regression Analysis between the Different Breast Dose Quantities Reported in Digital Mammography and Patient Age, Breast Thickness, and Acquisition Parameters

Breast cancer is the leading cause of cancer death among women worldwide. Screening mammography is considered the primary imaging modality for the early detection of breast cancer. The radiation dose from mammography increases the patients’ risk of radiation-induced cancer. The mean glandular dose (MGD), or the average glandular dose (AGD), provides an estimate of the absorbed dose of radiation by the glandular tissues of a breast. In this paper, MGD is estimated for the craniocaudal (CC) and mediolateral–oblique (MLO) views using entrance skin dose (ESD), X-ray spectrum information, patient age, breast glandularity, and breast thickness. Moreover, a regression analysis is performed to evaluate the impact of mammography acquisition parameters, age, and breast thickness on the estimated MGD and other machine-produced dose quantities, namely, ESD and organ dose (OD). Furthermore, a correlation study is conducted to evaluate the correlation between the ESD and OD, and the estimated MGD per image view. This retrospective study was applied to a dataset of 2035 mammograms corresponding to a cohort of 486 subjects with an age range of 28–86 years who underwent screening mammography examinations. Linear regression metrics were calculated to evaluate the strength of the correlations. The mean (and range) MGD for the CC view was 0.832 (0.110–3.491) mGy and for the MLO view was 0.995 (0.256–2.949) mGy. All the mammography dose quantities strongly correlated with tube exposure (mAs): ESD (R² = 0.938 for the CC view and R² = 0.945 for the MLO view), OD (R² = 0.969 for the CC view and R² = 0.983 for the MLO view), and MGD (R² = 0.980 for the CC view and R² = 0.972 for the MLO view). Breast thickness showed a better correlation with all the mammography dose quantities than patient age, which showed a poor correlation. Moreover, a strong correlation was found between the calculated MGD and both the ESD (R² = 0.929 for the CC view and R² = 0.914 for the MLO view) and OD (R² = 0.971 for the CC view and R² = 0.972 for the MLO view). Furthermore, it was found that the MLO scan views yield a slightly higher dose compared to CC scan views. It was also found that the glandular absorbed dose is more dependent on glandularity than size. Despite being more reflective of the dose absorbed by the glandular tissue than OD and ESD, MGD is considered labor-intensive and time-consuming to estimate.

Mean glandular dose in the mammary gland and dose of radiation in the thyroid gland and lens in women with and without breast implants during different modalities of mammography

There have always been concerns about the secondary effects of diagnostic methods that use ionizing radiation. During mammography, the parameters to be concerned about are the mean glandular dose and the scatter dose. We evaluated the dose of radiation to the breast, thyroid gland, and lens in digital mammography in women with and without implants, in tomosynthesis in women with and without implants, and in contrast-enhanced mammography.

MATERIALS AND METHODS

The study included 212 women with and without disease who were attended at the Centro Clínico de Estereotaxia, CECLINES, in Caracas, Venezuela, between June 2017 and August 2017; the women were classified into five groups according to the mammographic modality used to evaluate them and whether or not they had implants. The statistical analysis included descriptive statistics for the study population. We used the Mann-Whitney U to compare the mean glandular dose and dose in the thyroid gland and lens between groups.

RESULTS

The mean glandular dose and the dose of radiation received in the thyroid and lens were within the acceptable range. In a few exceptions, the mean glandular dose per view was slightly higher than 3 mGy. The scatter dose to the thyroid gland and the lens during mammography has a very small contribution to the annual dose equivalent.

CONCLUSION

The mean glandular dose and the scatter dose to the thyroid gland and lens delivered during tomosynthesis and 2D mammography in women with implants were higher than those delivered during other mammographic techniques in women without implants.

A review of screening mammography: The benefits and radiation risks put into perspective

INTRODUCTION/BACKGROUND

In medical imaging a benefit to risk analysis is required when justifying or implementing diagnostic procedures. Screening mammography is no exception and in particular concerns around the use of radiation to help diagnose cancer must be addressed.

METHODS

The Medline database and various established reports on breast screening and radiological protection were utilised to explore this review.

RESULTS/DISCUSSION

The benefit of screening is well argued; the ability to detect and treat breast cancer has led to a 91% 5-year survival rate and 497 deaths prevented from breast cancer amongst 100,000 screened women. Subsequently, screening guidelines by various countries recommend annual, biennial or triennial screening from ages somewhere between 40-74 years. Whilst the literature presents different perspectives on screening younger and older women, the current evidence of benefit for screening women <40 and ≥75 years is currently not strong. The radiation dose and associated risk delivered to each woman for a single examination is dependent upon age, breast density and breast thickness, however the average mean glandular dose is around 2.5-3 mGy, and this would result in 65 induced cancers and 8 deaths per 100,000 women over a screening lifetime from 40-74 years. This results in a ratio of lives saved to deaths from induced cancer of 62:1.

CONCLUSION

Therefore, compared to the potential mortality reduction achievable with screening mammography, the risk is small.

Comparison of Mean Glandular Dose between Full-Field Digital Mammography and Digital Breast Tomosynthesis

Early detection of breast cancer is diagnosed using mammography, the gold standard in breast screening. However, its increased use also provokes radiation-induced breast malignancy. Thus, monitoring and regulating the mean glandular dose (MGD) is essential. The purpose of this study was to determine MGD for full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) in the radiology department of a single centre. We also analysed the exposure factors as a function of breast thickness. A total of 436 patients underwent both FFDM and DBT. MGD was auto calculated by the mammographic machine for each projection. Patients' data included compressed breast thickness (CBT), peak kilovoltage (kVp), milliampere-seconds (mAs) and MGD (mGy). Result analysis showed that there is a significant difference in MGD between the two systems, namely FFDM and DBT. However, the MGD values in our centre were comparable to other centres, as well as the European guideline (<2.5 mGy) for a standard breast. Although DBT improves the clinical outcome and quality of diagnosis, the risk of radiation-induced carcinogenesis should not be neglected. Regular quality control testing on mammography equipment must be performed for dose monitoring in women following a screening mammography in the future.

The Effect of Breast Size and Density in Turkish Women on Radiation Dose in Full-Field Digital Mammography

Objective

The purpose of this study was to look into the relationship between breast size and mammographic breast density in women and breast radiation dose on full-field digital mammography (FFDM), as well as the factors that influence radiation dose.

Materials and Methods

The study included a total of 2,060 FFDM images from 515 consecutive participants. The participants were divided into two groups: those exposed to high doses (>3 mGy) and those exposed to low doses (<3 mGy). Moreover, the researchers analyzed the relationship between mean glandular dose (MGD) of the breast and patient age, compressed breast thickness, compression force, mammographic breast composition, and mammographic breast size.

Results

The mean mammographic breast volume was 936.2 ± 425.2 (114.5-3,018) mL, and the mean compressed breast tissue thickness was 56.75 ± 10.44 mm. Moreover, the mean MGD in the high-dose group was 3.51 ± 0.48 mGy and 1.92 ± 0.56 mGy in the low-dose group. The high-dose group had greater breast thickness, diameters, volume, compression pressure, and surgical rate. However, the high-dose group was younger and had less dense breasts. In multivariate logistic regression analysis, the most important predictors of dose determination were breast thickness [odds ratio (OR): 1.178, 95% confidence interval (CI): 1.156-1.200, p<0.001], history of previous surgery (OR: 2.210, 95% CI: 1.417-3.447, p<0.001), compression force (OR: 1.008, 95% CI: 1.004-1.013, p<0.001), and breast density (OR: 1.873, 95% CI: 1.359-2.580, p<0.001).

Conclusion

Women with larger breast volumes are subjected to higher doses of radiation. Therefore, breast-screening programs can be individualized to young women with larger breast volumes and women who have had breast-conserving surgery.

Establishment of regional diagnostic reference levels for digital mammography in Western Province of Sri Lanka

The radiation dose to the breasts should be kept to a minimum as breast tissues are highly sensitive to radiation. In mammography, the mean glandular dose (MGD) is used to specify the patient dose. In this study, data on the MGD during diagnostic mammographic examinations was collected using the database from six digital mammography facilities available in the Western Province in Sri Lanka. Examinations involving breast pathology, breast implants, or compressed breast thicknesses (CBT) outside the range of 20-110 mm were excluded in this study. The mean MGD per breast was 3.50 mGy, with a mean CBT of 57 mm. The mean MGD per facility varies from 1.58 to 2.27 mGy, with overall 75th and 95th percentiles of 2.15 and 2.82 mGy, respectively. The 75th and 95th percentile MGD per image, for the average CBT of 57 ± 12 mm, were 2.00 and 2.65 mGy respectively. The 75th percentile value of the MGD is suggested for the Western Province and it depends on the specific CBT.

Mean glandular dose in the mammary gland and dose of radiation in the thyroid gland and lens in women with and without breast implants during different modalities of mammography

There have always been concerns about the secondary effects of diagnostic methods that use ionizing radiation. During mammography, the parameters to be concerned about are the mean glandular dose and the scatter dose. We evaluated the dose of radiation to the breast, thyroid gland, and lens in digital mammography in women with and without implants, in tomosynthesis in women with and without implants, and in contrast-enhanced mammography.

MATERIALS AND METHODS

The study included 212 women with and without disease who were attended at the Centro Clínico de Estereotaxia, CECLINES, in Caracas, Venezuela, between June 2017 and August 2017; the women were classified into five groups according to the mammographic modality used to evaluate them and whether or not they had implants. The statistical analysis included descriptive statistics for the study population. We used the Mann-Whitney U to compare the mean glandular dose and dose in the thyroid gland and lens between groups.

RESULTS

The mean glandular dose and the dose of radiation received in the thyroid and lens were within the acceptable range. In a few exceptions, the mean glandular dose per view was slightly higher than 3mGy. The scatter dose to the thyroid gland and the lens during mammography has a very small contribution to the annual dose equivalent.

CONCLUSION

The mean glandular dose and the scatter dose to the thyroid gland and lens delivered during tomosynthesis and 2D mammography in women with implants were higher than those delivered during other mammographic techniques in women without implants.

Dose management software implementation in mammography

PURPOSE

This work aimed to evaluate the use of a dose management software (DMS) in mammography and analyse the clinical practice in terms of radiation exposure in screening and diagnostic mammography.

METHODS

Mean glandular dose (MGD) from approximately 10,000 images were collected and analysed taking into account anode/filter combination, projection, compressed breast thickness (CBT) and compression force. Causes of increased MGD were investigated and actions were taken when malpractice was detected.

RESULTS

MGD values for craniocaudal (CC) and mediolateral oblique (MLO) exposures for different CBT were defined. The average MGD for CBT of 60-69 mm was 1.84 mGy for CC images and 1.85 mGy for MLO images for screening examinations, while for diagnostic examinations the MGD was 1.95 mGy for CC and 2.01 mGy for MLO images. As no national diagnostic reference levels (DRLs) for mammography exist in Switzerland, typical mean glandular dose (MGD) values were defined as a first step towards their establishment for both screening and diagnostic examinations.

CONCLUSIONS

The use of DMS facilitated immensely the analysis of all clinical and technical parameters, the evaluation of radiation dose received by the patients, as well as the overall evaluation of radiographers' performance. The DMS disclosed the role of the medical physicist in dose management and optimization.

Estimation of cancer risks during mammography procedure in Saudi Arabia

The aims of the present work were to quantify radiation doses arises from patients' exposure in mammographic X-ray imaging procedures and to estimate the radiation induced cancer risk. Sixty patients were evaluated using a calibrated digital mammography unit at King Khaled Hospital and Prince Sultan Center, Alkharj, Saudi Arabia. The average patient age (years) was 44.4 ± 10 (26-69). The average and range of exposure parameters were 29.1 ± 1.9 (24.0-33.0) and 78.4 ± 17.5 (28.0-173.0) for X-ray tube potential (kVp) and current multiplied by the exposure time (s) (mAs), respectively. The MGD (mGy) per single projection for craniocaudal (CC), Medio lateral oblique (MLO) and lateromedial (LM) was 1.02 ± 0.2 (0.4-1.8), 1.1 ± 0.3 (0.5-1.8), 1.1 ± 0.3 (0.5-1.9) per procedure, in that order. The average cancer risk per projection is 177 per million procedures. The cancer risk is significant during multiple image acquisition. The study revealed that 80% of the procedures with normal findings. However, precise justification is required especially for young patients.